@revanceaesthetics

Committed to Science-Backed Innovation in Facial Injectables.

Revance and Teoxane Announce the FDA Approval of RHA® Dynamic Volume for Midface Contour Deficiencies
Register for Teoxane RHA® Collection and DAXXIFY® Virtual Trainings
Revance Aesthetics Patient DAXXIFY® Radiant Rewards Rebate
Revance Aesthetics Patient DAXXIFY® Radiant Rewards Rebate
Crown Laboratories Now Operates Under the Name Revance
Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials
Revance Aesthetics
DAXXIFY® (daxibotulinumtoxinA⁃lanm) Injection
DAXXIFY® Prescribing Information and Medication Guide
Teoxane RHA® Collection
Partner with Us

View on mobile